SecBot SecBot
Insider Cluster (5 insiders) ·Filed Jun 15, 2026

ONC

BeOne Medicines Ltd.
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago
Insider cluster: 5 insiders, $2.0M total
Actionable Insight • Neutral

The insider selling is immaterial and likely driven by routine tax or diversification planning following equity grants. No actionable signal for traders; monitor for any material corporate events that might prompt larger-scale insider activity.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$263.92
T+0 close · Jun 15, 2026 · via day close
Latest settled
+29.51%
T+60 · $341.80
Vs SPY
+28.51%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 16 $263.92entry
  2. T+1 · 5mo ago −0.47%α +0.78% · $262.68
  3. T+5 · 5mo ago +4.63%α +6.86% · $276.13
  4. T+20 · 4mo ago +16.16%α +15.96% · $306.56
  5. T+60 · 2mo ago +29.51%α +28.51% · $341.80
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Five BeOne Medicines insiders, including the CEO, sold a total of $1.98M in open-market shares over a one-week window. The selling is trivial relative to the $29.4B market cap (0.007%), and the cluster is accompanied by large equity grants to the same executives, suggesting routine compensation-related liquidity rather than a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$2.0M
Insiders
5

Key Facts

  • CEO John Oyler sold $1.03M worth of shares on 2026-06-08.
  • Total open-market sales by 5 insiders: $1.98M.
  • Total sales represent ~0.007% of ONC's $29.4B market cap.
  • Multiple executives received large equity grants (non-cash) on the same date as some sales.

Financial Impact

Total insider sales of $1.98M, negligible relative to $29.4B market cap.

insider ownership

Risk Factors

  • Insider selling could accelerate if executives perceive headwinds, but current levels are insignificant.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ONC-1781560626867

Track record

27 reports on ONC

Performance horizon

3 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +12.55% at T+60 after the Aug 5, 2026 report. 4 of 7 went positive at some point.

Filters
  1. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $416.54 Now $411.29 −1.26% settles Nov 23
  2. Nov 10, 20266d ago Insider Cluster Neutral 3/10 Entry $419.98 Now $411.29 −2.07% settles Nov 18
  3. Nov 6, 202610d ago 144 Neutral 2/10 Entry $417.33 to $411.29 Now $411.29 −1.45% ▼ −1.45% +0.25% vs SPY
  4. Nov 5, 202611d ago 144 Neutral 2/10 Entry $406.96 to $416.54 Now $411.29 +1.06% ▲ +2.35% −0.24% vs SPY
  5. Nov 5, 202611d ago 8-K Bullish 6/10 Entry $387.25 to $415.96 Now $411.29 +6.21% ▲ +7.41% +4.12% vs SPY
  6. Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $377.78 to $419.98 Now $411.29 +8.87% ▲ +11.17% +12.08% vs SPY
  7. Oct 2, 20266w ago Insider Cluster Bearish 5/10 Entry $361.65 to $350.40 Now $411.29 −13.73% ▲ +3.11% +3.53% vs SPY
  8. Sep 22, 20267w ago Institutional Cluster Mixed 4/10 Entry $368.08 to $365.27 Now $411.29 +11.74% ▼ −0.76% +0.42% vs SPY
  9. Sep 10, 20269w ago Insider Cluster Neutral 3/10 Entry $346.51 to $350.84 Now $411.29 +18.69% ▲ +1.25% +1.47% vs SPY
  10. Sep 3, 202610w ago Insider Cluster Neutral 2/10 Entry $358.26 to $353.83 Now $411.29 +14.80% ▼ −1.24% −0.03% vs SPY
Showing 10 of 27

US Market Status

Market Closed · Opens Wed (11h 43m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 15, 2026